7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

Novo Nordisk
(NYSE:NVO) 

NVO stock logo

Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1...

Founded: 1923
Full Time Employees: 44,326
Sector: Healthcare
Industry: Biotechnology
blind

Share this website to your friends
Novo Nordisk Number of Twitter Followers
202204 202205 202206 202207 202208 202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 06.6813.3620.0426.7233.440.0846.76Thousand
Novo Nordisk Days Payable Outstanding ttm (DPO)
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 037.3374.66112149.33186.66223.99261.32
Novo Nordisk Days Receivable Outstanding ttm (DSO)
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 018.2636.5354.7973.0691.32109.59127.85
Novo Nordisk Days Inventory Outstanding ttm (DIO)
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 046.3892.76139.15185.53231.91278.29324.68
Novo Nordisk Op Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 05.7111.4217.1322.8428.5534.2639.97
Novo Nordisk Free Cashflow Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 04.298.5912.8817.1821.4725.7730.06
Novo Nordisk Cash Per Share ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 02.374.737.19.4711.8414.216.57
Novo Nordisk P/S ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 07.9415.8823.8231.7539.6947.6355.57
Novo Nordisk (GAAP) P/E ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 025.9351.8577.78103.7129.63155.55181.48
Novo Nordisk P/B ratio ttm
202209 202210 202211 202212 202301 202302 202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 05.410.816.221.6127.0132.4137.81
No extra charts and metrics for this ticker.